Verastem (VSTM) Operating Expenses (2011 - 2026)

Verastem's Operating Expenses history runs 16 years deep, the most recent figure standing at $63.6 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 43.9% year-over-year to $63.6 million in Q1 2026; TTM through Mar 2026 was $220.4 million, a 56.26% increase from a year earlier, with the FY2025 full-year figure at $201.0 million, up 60.89% from the prior year.
• Operating Expenses advanced to $63.6 million in Q1 2026 per VSTM's latest filing, from $59.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $63.6 million in Q1 2026 and bottomed at $16.8 million in Q4 2022.
• The 5-year median for Operating Expenses is $28.3 million (2024), against an average of $32.8 million.
• Across the five-year window, Operating Expenses slipped 5.19% in 2023 and surged 86.8% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $16.8 million in 2022, then surged by 84.85% to $31.1 million in 2023, then gained by 1.45% to $31.6 million in 2024, then jumped by 86.8% to $59.0 million in 2025, then rose by 7.72% to $63.6 million in 2026.
• Per Business Quant, the three latest VSTM Operating Expenses figures stand at $63.6 million (Q1 2026), $59.0 million (Q4 2025), and $52.0 million (Q3 2025).